BRUCE ROBINSON, MD, PH.D.

Bruce joined agency promotions after years in the molecular biology of cancer research (PhD) and Anatomic and Forensic Pathology (MD). His focus of 20+ years has been aligning medical sciences of the molecule to the proper audiences, including CNS therapeutics ProSom, Gilenya, Shingrix, Pristiq, Vivitrol, and Vimovo, to name a few.